0001237899-14-000034.txt : 20140318 0001237899-14-000034.hdr.sgml : 20140318 20140318170936 ACCESSION NUMBER: 0001237899-14-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140317 FILED AS OF DATE: 20140318 DATE AS OF CHANGE: 20140318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWN MICHAEL S CENTRAL INDEX KEY: 0001174475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 14701777 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-03-17 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001174475 BROWN MICHAEL S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2014-03-17 4 M 0 2000.0 33.42 A 16662 D Common Stock 2014-03-17 4 S 0 1100.0 333.42 D 15562 D Common Stock 2014-03-17 4 S 0 500.0 334.59 D 15062 D Common Stock 2014-03-17 4 S 0 100.0 335.69 D 14962 D Common Stock 2014-03-17 4 S 0 300.0 336.49 D 14662 D Common Stock 2700 I by Trust 2 Non-Qualified Stock Option (right to buy) 33.42 2014-03-17 4 M 0 2000.0 0.0 D 2021-01-03 Common Stock 2000 3000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 1,100 shares of Company stock on March 17, 2014 at prices ranging from $333.04 to $333.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2014 at each separate price. Represents volume-weighted average price of sales of 500 shares of Company stock on March 17, 2014 at prices ranging from $334.46 to $334.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2014 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Michael S. Brown 2014-03-17